1. Home
  2. HCM vs BB Comparison

HCM vs BB Comparison

Compare HCM & BB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • BB
  • Stock Information
  • Founded
  • HCM 2000
  • BB 1984
  • Country
  • HCM Hong Kong
  • BB Canada
  • Employees
  • HCM N/A
  • BB N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • BB
  • Sector
  • HCM Health Care
  • BB
  • Exchange
  • HCM Nasdaq
  • BB Nasdaq
  • Market Cap
  • HCM 2.6B
  • BB 2.7B
  • IPO Year
  • HCM N/A
  • BB 1997
  • Fundamental
  • Price
  • HCM $15.10
  • BB $4.56
  • Analyst Decision
  • HCM Sell
  • BB Hold
  • Analyst Count
  • HCM 1
  • BB 6
  • Target Price
  • HCM $13.75
  • BB $4.98
  • AVG Volume (30 Days)
  • HCM 43.6K
  • BB 13.8M
  • Earning Date
  • HCM 08-07-2025
  • BB 09-25-2025
  • Dividend Yield
  • HCM N/A
  • BB N/A
  • EPS Growth
  • HCM N/A
  • BB N/A
  • EPS
  • HCM 0.53
  • BB N/A
  • Revenue
  • HCM $602,197,000.00
  • BB $536,600,000.00
  • Revenue This Year
  • HCM N/A
  • BB $2.43
  • Revenue Next Year
  • HCM $15.49
  • BB $7.41
  • P/E Ratio
  • HCM $5.61
  • BB N/A
  • Revenue Growth
  • HCM N/A
  • BB N/A
  • 52 Week Low
  • HCM $11.51
  • BB $2.24
  • 52 Week High
  • HCM $21.50
  • BB $6.24
  • Technical
  • Relative Strength Index (RSI)
  • HCM 39.12
  • BB 52.48
  • Support Level
  • HCM $14.86
  • BB $4.45
  • Resistance Level
  • HCM $15.34
  • BB $5.09
  • Average True Range (ATR)
  • HCM 0.32
  • BB 0.23
  • MACD
  • HCM -0.06
  • BB -0.04
  • Stochastic Oscillator
  • HCM 7.79
  • BB 28.61

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About BB BlackBerry Limited

BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.

Share on Social Networks: